December 01, 2014 – According to the World Health Organization (WHO), Human Immunodeficiency Virus (HIV/AIDS) has caused the deaths of millions of people and is one of the most destructive pandemics in history. World AIDS Day, celebrated annually on December 1st, was established by the WHO in 1988 to raise awareness of the virus, which is preventable and treatable.

HIV attacks the body’s immune system, the body’s defense against diseases. HIV can be passed on through infected bodily fluids, most commonly …

December 01, 2014 – According to the World Health Organization (WHO), Human Immunodeficiency Virus (HIV/AIDS) has caused the deaths of millions of people and is one of the most destructive pandemics in history. World AIDS Day, celebrated annually on December 1st, was established by the WHO in 1988 to raise awareness of the virus, which is preventable and treatable.

HIV attacks the body’s immune system, the body’s defense against diseases. HIV can be passed on through infected bodily fluids, most commonly …

Tokyo, Japan, December 1, 2014 ― Sandoz, the generic pharmaceutical division of Novartis, today announced the launch in Japan of biosimilar Filgrastim BS Injection 75µg / 150µg / 300µg Syringe. Filgrastim is used with certain cancer patients to accelerate recovery of infection-fighting white blood cells after chemotherapy (prevention of neutropenia) and is also used to stimulate mobilization of hematopoietic stem cells for collection and transplantation.

“As the pioneer and global leader in biosimilars we are very pleased to announce the launch of our second …

Tokyo, Japan, December 1, 2014 ― Sandoz, the generic pharmaceutical division of Novartis, today announced the launch in Japan of biosimilar Filgrastim BS Injection 75µg / 150µg / 300µg Syringe. Filgrastim is used with certain cancer patients to accelerate recovery of infection-fighting white blood cells after chemotherapy (prevention of neutropenia) and is also used to stimulate mobilization of hematopoietic stem cells for collection and transplantation.

“As the pioneer and global leader in biosimilars we are very pleased to announce the launch of our second …